Document Detail

Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
MedLine Citation:
PMID:  19160539     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aims of our study were to ascertain the proportion of Fusarium onychomycosis among patients with suspected onychomycosis, to record clinical features and to assess the efficacy of itraconazole pulse therapy in treatment. METHODS: Six patients with positive isolates of Fusarium sp were treated in an open, prospective manner with itraconazole: two pulses for fingernails and three pulses for toenails. Significant growth of Fusarium sp was considered when both microscopy of direct mounts in KOH and culture were positive for mold. Efficacy parameters were mycological cure and clinical cure. Mycological cure was negative direct microscopy (KOH) and culture. Clinical cure was complete absence of signs of onychomycosis. RESULTS: Prevalence of Fusarium onychomycosis was 6.25% (8/128). Three women and three men were studied. All had bilateral big toenails involved which were of the distal and lateral onychomycosis. Three of them had associated fingernail onychomycosis with periungual inflammation. All our patients were immunocompetent. At month 12 from the start of treatment, mycological cure was 100% while only three out of five patients showed normal nail growth and clinical cure. There were no significant clinical or laboratory adverse effects. CONCLUSIONS: Our data reconfirmed that Fusarium nail infections are difficult to eradicate. Since the therapeutic reservoir in toenails is 11 months, these patients should be followed up for a total of 12 months before coming to the final conclusion.
Ranthilaka R Ranawaka; Nelun de Silva; Ramya W Ragunathan
Related Documents :
18087629 - Tuberculous arthritis--a fourteen-year experience at a tertiary teaching hospital in ta...
16906399 - Hypokalemic rhabdomyolysis in a child due to amphotericin b therapy.
11413929 - One week pulse therapy with itraconazole (200 mg day-1) for onychomycosis. evaluation o...
16857689 - Efficacy and tolerability of daily-half dose linezolid in patients with intractable mul...
9470329 - Maintenance therapy with itraconazole after treatment of cryptococcal meningitis in the...
10524579 - How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
10101549 - Is it feasible to use magnesium sulphate as a hypotensive agent in oral and maxillofaci...
22395509 - Healing process and laser therapy in the superficial periodontium: a histological study.
12419929 - Usefulness of the symphony nitinol stent for arteriosclerosis obliterans.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of dermatological treatment     Volume:  19     ISSN:  0954-6634     ISO Abbreviation:  J Dermatolog Treat     Publication Date:  2008  
Date Detail:
Created Date:  2009-01-22     Completed Date:  2009-03-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8918133     Medline TA:  J Dermatolog Treat     Country:  England    
Other Details:
Languages:  eng     Pagination:  308-12     Citation Subset:  IM    
Teaching Hospital Karapitiya, Galle, Sri Lanka.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifungal Agents / therapeutic use*
Cohort Studies
Foot Dermatoses / drug therapy,  epidemiology,  microbiology*
Itraconazole / therapeutic use*
Middle Aged
Onychomycosis / drug therapy,  epidemiology,  microbiology*
Sri Lanka
Reg. No./Substance:
0/Antifungal Agents; 84625-61-6/Itraconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  An urticarial vasculitis case induced by glatiramer acetate.
Next Document:  The IKK-related kinases: from innate immunity to oncogenesis.